Navigation Links
NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually
Date:12/8/2011

ZURICH, December 9, 2011 /PRNewswire/ --

NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System

Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports innovators, commissioners, and clinicians to speed up the development and use of innovations that will benefit the NHS.

Brian Winn, Head of the National Innovation Centre, explains, "Sequana Medical's ALFApump System is a revolutionary fluid management solution for patients with ascites which could save the NHS significant amounts of money by eliminating the costs associated with repeat medical interventions whilst significantly improving patients' Quality of Life."

The ALFApump System is indicated for the management of refractory and recurrent ascites due to liver cirrhosis, a condition where massive and uncontrolled fluid accumulation occurs in the abdominal cavity. The fully implantable battery powered pump system slowly removes ascites as it forms by transferring it to the bladder where it is eliminated through normal urination.  This condition affects around 3,000 people in the UK a year.

Rajiv Jalan, Professor of Hepatology, UCL, and Honorary Consultant, Royal Free Hospital, London, comments, "The ALFApump System is an exciting innovation in the care of refractory ascites patients for whom current treatment options are very limited."  

Patients are typically managed with large-volume paracentesis, an invasive procedure in which the ascites is drained over a number of hours through a large needle inserted in the abdomen.

Dr Farzana Malik, Vice President of Market Access at Sequana Medical explains, "I am delighted that the National Innovation Centre has recognized the considerable economic benefits to the NHS offered by the ALFApump System. This is a unique technology that provides significant benefits for patients, clinicians and the NHS."

The ALFApump System was granted CE Mark in July 2011 and is currently being launched in leading hepatology centres across Europe by Sequana Medical.

About Sequana Medical:

Sequana Medical is a Swiss medical device company dedicated to improving patient lives through innovative technologies to manage fluid within the body.

Contact:
Sequana Medical
Emily Woodward
Product Marketing Manager
Emily.woodward@sequanamedical.com
Tel: +41-44-446-5074
http://www.sequanamedical.com



'/>"/>
SOURCE Sequana Medical AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
2. New MediCare International Excess Options Give up to 50% Premium Discount
3. Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference
4. Chindex International, Inc. to Present at the 22nd Annual Oppenheimer Healthcare Conference
5. National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week
6. National Influenza Vaccination Week is December 4 - 10, 2011
7. Bupa International Releases Health Guides to Hong Kong and Singapore
8. Leading Indian CRO Max Neeman International Expands in Response to Positive Biosimilars Market in India
9. National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nations Capitol
10. Tom Hall Named National Sales and Marketing Director for VR Laboratories
11. Instrumentation Laboratory Introduces Automated HemosIL VWF Ristocetin Cofactor Activity Assay in Europe and International Regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- Summary This report provides all ... its partnering interests and activities since 2010. Description The ... insight into the partnering activity of one of the world,s ... are prepared upon purchase to ensure inclusion of the most ... report will be delivered in PDF format within 1 working ...
(Date:3/27/2017)... -- A recent study at Shriners Hospitals for Children – ... country dedicated to the treatment of pediatric burns and ... Surfacide Helios ® UV-C Disinfection System is ... not killed by the EVS (manual) cleaning process alone." ... Association,s 49th Annual Meeting in Boston ...
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, ... intends to offer shares of common stock in an ... on file with the Securities and Exchange Commission (the ... conditions, and there can be no assurance as to ... as to the actual size or terms of the ...
Breaking Medicine Technology:
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Usually, ... from the daily wardrobe. However, for those self-conscious about a double chin, this means ... have the ideal solution. , “For most people, a double chin is undesirable,” ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... has relocated its corporate headquarters to a new, more expansive office space in ... October 2016, Qualidigm purchased a distressed office building in Wethersfield, Conn. located at ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... work, the Self-Funding Success website has recently developed and published an informational resource ... ” was created based on common inquiries the site’s team of third party ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... which will be offered by the American Association of Integrative Medicine and available ... for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With expansion and ... Georgia, in early March. , The seed processing plant opened in Marshallville in 2006, ... 2016. The new office allows opportunity for transition of Patten Seed operations to the ...
Breaking Medicine News(10 mins):